Detlev Ganten
Vorsitzender bei Charité - Universitätsmedizin Berlin
Aktive Positionen von Detlev Ganten
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Charité - Universitätsmedizin Berlin | Vorsitzender | 01.01.2005 | - |
| Max Planck Institute of Colloids & Interfaces | Vorsitzender | 01.01.2010 | - |
| GlycoUniverse GmbH & Co KGaA | Direktor/Vorstandsmitglied | - | - |
Eckert & Ziegler AG
 Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Direktor/Vorstandsmitglied | - | - |
| World Health Summit | Präsident | 01.01.2009 | - |
| Max Planck Institute of Molecular Plant Physiology | Vorsitzender | - | - |
Karriereverlauf von Detlev Ganten
Ehemalige bekannte Positionen von Detlev Ganten
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ECKERT & ZIEGLER SE | Direktor/Vorstandsmitglied | 20.05.2009 | 29.05.2019 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Direktor/Vorstandsmitglied | 01.01.1991 | 01.01.2004 |
| Université PSL | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Detlev Ganten
| McGill University | Doctorate Degree |
| Eberhard Karls Universität Tübingen | Undergraduate Degree |
Statistik
International
| Deutschland | 10 |
| Kanada | 2 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 5 |
| Chairman | 3 |
| President | 1 |
Sektoral
| Consumer Services | 6 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ECKERT & ZIEGLER SE | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
Eckert & Ziegler AG
Eckert & Ziegler AG Hospital/Nursing ManagementHealth Services Eckert & Ziegler AG is a leading specialist in isotope-related components for nuclear medicine and radiation therapy. The private company has a global presence of subsidiaries in several regions and is based in Berlin, DE. With nearly 1,000 employees, the German company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. The CEO of the company is Andreas Eckert. | Health Services |
| GlycoUniverse GmbH & Co KGaA | |
| World Health Summit | |
| Max Planck Institute of Molecular Plant Physiology |
- Börse
- Insiders
- Detlev Ganten
- Erfahrung